Facility Design and Engineering

Aug 01, 2007
BioPharm International
By BioPharm International Editors
The mounting threats of pandemic influenza, bioterrorism, and emerging infectious diseases continue to be the focus of research programs and funding initiatives, not only within governmental agencies, but also universities, private research firms, and commercial manufacturing entities. With all of these efforts, however, the question of manufacturing capacity and the ability to respond to pandemic and emerging threats continues to be a major concern.
Jun 21, 2007
BioPharm International
By BioPharm International Editors
Intas Biopharmaceuticals Limited (IBPL, Gujarat, India, www.intasbiopharma.co.in) has become India's first dedicated biopharmaceutical company to receive certification from the European Agency for the Evaluation of Medicinal Products (EMEA, London, UK, www.emea.europa.eu) or an EU-GMP certification for its manufacturing facility at Ahmedabad, Gujarat.
Jun 21, 2007
BioPharm International
By BioPharm International Editors
The FDA issued MedImmune, Inc. (Gaithersburg, MD, www.medimmune.com), a warning letter for violating the agency's manufacturing rules and held off approving the company's influenza vaccine for use in children younger than age five until the problems are resolved.
Jun 21, 2007
BioPharm International
By BioPharm International Editors
Roche (Basel, Switzerland, www.roche.com) has opened its new biotechnology production center in Basel.
Jun 01, 2007
BioPharm International
By BioPharm International Editors
Discrete simulation allows the design teams to see every meaningful detail about equipment and materials flowing through the process.
May 23, 2007
BioPharm International
By BioPharm International Editors
Eden Biodesign (Liverpool, UK, www.edenbiodesign.com), SAFC (St. Louis, MO, www.sigmaaldrich.com/SAFC/Pharma), Midatech Group (Oxfordshire, OX, www.midatechgroup.com), Cellexus Systems (Cambridgeshire, UK, www.cellexusbiosystems.com), and BioConvergence LLC (Bloomington, IN, www.bioc.us) are sprucing up their product development and services with the construction of new manufacturing facilities.
Apr 22, 2007
BioPharm International
By BioPharm International Editors
Singapore's efforts to grow its biologics manufacturing sector received a significant boost on March 28, 2007, when the Singapore Economic Development Board (EDB) announced that Genentech, Inc. (San Francisco, CA, www.gene.com) has decided to establish a commercial-scale microbial-based biologics manufacturing facility in Singapore.
Apr 22, 2007
BioPharm International
By BioPharm International Editors
Abbott (Abbott Park, IL, www.abbott.com) recently announced the official opening of its new biologics manufacturing facility in Puerto Rico to support the long-term supply of its leading biologic agent, HUMIRA (adalimumab), and other future biologics.
Sep 01, 2006
BioPharm International
By BioPharm International Editors
Steam traps are part of a steam-in-place system. The current design allots 18 in. of vertical leg for condensate backup. A design with a sensitive bellows has been proven in laboratory tests to need only 6 in. of vertical leg during the 15 min. of 121?C sterilization. Loads of 1 to 27 lb/h are covered by the capability of the new trap, equivalent to required steam for vessels 20 to 40,000 L.
Aug 01, 2006
BioPharm International
By BioPharm International Editors
Understand your company's requirements, define responsibilities,and manage your team effectively.
native1_300x100
lorem ipsum